ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.018,39
-0,34%
US Dollar vs BRL
5,1958
0,00%
Bitcoin
57.271,30
-1,66%
Brent Oil
83,925
0,46%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Europa
  5. EU
  6. Innate Pharma (IPH)

  7. Innate Pharma (IPH) Notícias

IPH Innate Pharma

2,205
-0,025 (-1,12%)
30 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Innate Pharma IPH Euronext Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,025 -1,12% 2,205 12:40:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,245 2,20 2,245 2,205 2,23
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/04/202402:00BWL’Assemblée Générale d’Innate Pharma aura lieu le 23 mai..
10/04/202402:00BWInnate Pharma présente des données d’efficacité précliniques..
09/04/202402:00BWInnate Pharma Announces Its Participation in Upcoming..
05/04/202404:34BWInnate Pharma Files Its 2023 Universal Registration Document..
21/03/202403:00BWInnate Pharma Reports Full Year 2023 Financial Results and..
19/03/202403:00BWInnate Pharma annonce sa participation à une prochaine..
14/03/202403:00BWInnate Pharma Announces Conference Call and Webcast for Full..
06/03/202403:00BWINNATE PHARMA: TRAITEMENT DU PREMIER PATIENT DANS L’ESSAI DE..
21/02/202403:00BWInnate Pharma Announces Its Participation to Upcoming..
12/01/202403:00BWNouveau nombre d’actions et de droits de vote d’Innate..
04/01/202403:00BWInnate Pharma Announces U.S. FDA Lifts Partial Clinical Hold..
04/01/202402:59BWInnate Pharma Strengthens Leadership and Appoints Two New..
19/12/202309:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202303:00BWInnate Pharma Announces Licensing of a Fourth Natural Killer..
18/12/202303:00BWInnate Pharma Announces Leadership Change
11/12/202303:00BWInnate Pharma Shares Efficacy and Safety Phase 1 /2 Results..
10/12/202303:00BWInnate Pharma Presents Positive Results From TELLOMAK Phase..
27/11/202303:00BWInnate Pharma organise une conférence virtuelle avec un..
14/11/202303:00BWInnate Pharma présente ses résultats financiers au troisième..
07/11/202303:00BWInnate Pharma organise une conférence téléphonique pour ses..
03/11/202303:00BWInnate Pharma annonce la présentation de nouvelles données..
27/10/202302:00BWInnate Pharma annonce sa participation à de prochaines..
19/10/202302:00BWInnate Pharma publie son calendrier financier pour 2024
16/10/202302:00BWInnate Pharma Announces Abstracts Selected for ESMO Congress..
09/10/202302:00BWNouveau nombre d’actions et de droits de vote d’Innate..
05/10/202309:14DJNInnate Pharma Shares Fall Premarket on FDA Partial Study..
05/10/202302:00BWInnate Pharma annonce une mise à jour sur le programme..
22/09/202302:00BWInnate Pharma présente les données d’efficacité..
14/09/202302:00BWInnate Pharma Reports First Half 2023 Financial Results and..
29/08/202302:00BWInnate Pharma Announces Its Participation to Upcoming..
10/08/202302:00BWInnate Pharma to Participate in Upcoming Investor Conference
11/07/202302:00BWPremier patient traité dans l'essai clinique de Phase 1/2..
07/07/202302:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
26/06/202302:00BWInnate Pharma: First Patient Dosed in Phase 2 MATISSE Trial..
16/06/202302:00BWInnate Pharma Highlights Increased Lacutamab Clinical..
12/06/202302:00BWInnate Pharma présentera des données d’efficacité mises à..
10/06/202302:00BWInnate Pharma présente IPH6501, son NK Cell Engager ANKET®..
08/06/202311:53DJNInnate Pharma Shares Rise 8% After Cancer Treatment Gets..
08/06/202302:00BWSAR’579 / IPH6101 Receives FDA Fast Track Designation in the..
07/06/202302:00BWNouveau nombre d’actions et de droits de vote d’Innate..
26/05/202302:00BWInnate Pharma annonce les premières données d’escalade de..
23/05/202302:00BWInnate Pharma to Participate in Upcoming Investor..
15/05/202302:00BWInnate Pharma présentera des données précliniques pour..
12/05/202317:00BWRésultats de l’Assemblée Générale mixte du 12 mai 2023
10/05/202302:00BWInnate Pharma Reports First Quarter 2023 Financial Results..
09/05/202302:00BWNouveau nombre d’actions et de droits de vote d’Innate..
03/05/202302:00BWInnate Pharma annonce plusieurs abstracts cliniques acceptés..

Seu Histórico Recente

EU
IPH
Innate Pharma
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados